Found 7 matching trials
Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication PHASE2 The purpose of this study is to evaluate the safety and efficacy of K-134 f...
Show More Location
Multiple Locations
Learn More & Join Trial
Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients NA To identify the high-risk patients who might have in-stent thrombosis after...
Show More Location
Fuwai Cardiovascular Hospital
Learn More & Join Trial
Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism PHASE4 The purpose of this study is to determine the impact of adjunctive cilostaz...
Show More Location
Gyeongsang National University Hospital
Learn More & Join Trial
Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism PHASE3 The purpose of this study was to determine the impact of adjunctive cilosta...
Show More Location
Gyeong-Sang National University Hospital
Learn More & Join Trial
EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) PHASE2 This study aims to evaluate the efficacy of Y-6 sublingual tablets in impro...
Show More Location
Multiple Locations
Learn More & Join Trial
Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism PHASE4 Percutaneous coronary intervention (PCI) with stent implantation is the pre...
Show More Location
Gyeongsang National University Hospital
Learn More & Join Trial
Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease PHASE4 Impaired renal function is associated with reduced responsiveness to clopid...
Show More Location
Kyung Hee University
Learn More & Join Trial